Atrial capture verification

• US 7,957,803 B2
• Filed: 08/13/2009
• Issued: 06/07/2011
• Est. Priority Date: 12/15/2004
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Garg, Ankur, Zhang, Geng, Daum, Douglas R.
• Primary Examiner(s): Layno; Carl H
• Assistant Examiner(s): MALAMUD, DEBORAH LESLIE
• Application Number:
  US12/540,902
• Publication Number:
  US 20090306737A1
• Time in Patent Office: 663 Days
• Field of Search: 607 1- 2, 607/9, 607/14, 607 27- 28
• US Class Current: 607/28
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions
• CPC Class Codes: A61N 1/3712 Auto-capture, i.e. automatic adjustment of the stimulation threshold
• CPC Class Codes: A61N 1/3714 Atrial capture

Abstract

Methods and systems for classifying cardiac responses to pacing stimulation and/or preventing retrograde cardiac conduction are described. Following delivery of a pacing pulse to an atrium of the patient'"'"'s heart during a cardiac cycle, the system senses in the atrium for a retrograde P-wave. The system classifies the atrial response to the pacing pulse based on detection of the retrograde P-wave. The system may also sense for an atrial evoked response and utilize the atrial evoked response in classifying the cardiac pacing response.

Claims

1. An implantable cardiac device, comprising:

a plurality of implantable cardiac electrodes configured to be electrically coupled to a heart;

sensing circuitry configured to sense cardiac signals;

a processor configured to

control delivery of a first pacing pulse to an atrium during a first cardiac cycle,

sense for an atrial evoked response following delivery of and associated with the first atrial pacing pulse,

sense for an intrinsic activation of a ventricle during the first cardiac cycle,

deliver a pacing pulse to the ventricle if the intrinsic ventricular activation is not sensed during the first cardiac cycle,

sense in the atrium for a retrograde P-wave, the retrograde P-wave responsive to the ventricular pacing pulse or the intrinsic ventricular activation,

classify the cardiac response to the first atrial pacing pulse as a non-captured response if the retrograde P-wave is detected and the atrial evoked response is not detected,

classify the cardiac response to the first atrial pacing pulse as a captured response if the atrial evoked response is detected, and,

deliver, during a second cardiac cycle immediately following the first cardiac cycle, a second atrial pacing pulse to the atrium, the second atrial pacing pulse having a scheduled delivery time, but the second atrial pacing pulse being delivered at a time that is delayed relative to the scheduled delivery time if the cardiac response of the first atrial pacing pulse is classified as a non-captured response and if a time period between the detected retrograde P-wave and the scheduled delivery time is no greater than an atrial effective refractory period (AERP).

2. The device of claim 1, wherein the processor is configured to sense for the retrograde P during a time interval following sensing intrinsic ventricular activity or delivery of the ventricular pacing pulse.

3. The device of claim 2, wherein the time interval comprises a post ventricular atrial refractory period.

4. The device of claim 2, wherein the time interval begins about 100 milliseconds following delivery of the ventricular pacing pulse and ends about 500 milliseconds following delivery of the ventricular pacing pulse.

5. The device of claim 1, wherein the processor is further configured to

deliver additional atrial pacing pulses during cardiac cycles subsequent to the cardiac cycle,

deliver additional ventricular pacing pulses during the subsequent cardiac cycles,

sense in the atrium for retrograde P-waves, the retrograde P-waves respectively responsive to the additional ventricular pacing pulses, and

classify cardiac responses to the additional atrial pacing pulses as non-captured responses if the retrograde P-waves are detected.

6. The device of claim 5, wherein the processor is configured to deliver atrial pacing pulses, deliver ventricular pacing pulses, sense in the atrium, and classify the cardiac responses beat-by-beat during a pacing therapy delivered to a patient.

7. The device of claim 5, wherein the processor is configured to deliver the atrial pacing pulses, deliver the ventricular pacing pulses, sense in the atrium, and classify the cardiac responses during a test to determine a capture threshold of the atrium.

8. The device of claim 1, wherein the processor is configured to sense in the atrium for a retrograde P-wave during a post ventricular atrial refractory period.

9. The device of claim 1, wherein the processor is further configured to

deliver additional atrial pacing pulses during cardiac cycles subsequent to the cardiac cycle,

sense for atrial evoked responses following delivery of the additional atrial pacing pulses,

sense in the atrium for retrograde P-waves, the retrograde P-waves responsive to ventricular pacing pulses or the intrinsic ventricular activations during the subsequent cardiac cycles, and

classify the cardiac responses to the additional atrial pacing pulses based on the sensed atrial evoked responses and the sensed retrograde P-waves, wherein the processor is configured to deliver the atrial pacing pulses, sense in the atrium, and classify the cardiac responses beat-by-beat during a pacing therapy delivered to a patient.

10. The device of claim 1, wherein the processor is further configured to

deliver additional atrial pacing pulses during cardiac cycles subsequent to the cardiac cycle,

sense for atrial evoked responses following delivery of the additional atrial pacing pulses,

sense in the atrium for retrograde P-waves, the retrograde P-waves responsive to ventricular pacing pulses or the intrinsic ventricular activations during the subsequent cardiac cycles, and

classify the cardiac responses to the additional atrial pacing pulses based on the sensed atrial evoked responses and the sensed retrograde P-waves, wherein the processor is configured to deliver the atrial pacing pulses, sense in the atrium, and classify the cardiac responses are performed during a test to determine a capture threshold of the atrium.

11. The device of claim 1, wherein the processor is further configured to deliver, during a second cardiac cycle immediately following the first cardiac cycle, a second atrial pacing pulse to the atrium, the second atrial pacing pulse having an increased energy relative to the first atrial pacing pulse if the cardiac response of the first atrial pacing pulse is classified as a non-captured response.

12. The device of claim 1, wherein the processor is configured to increase the AERP if the second atrial pacing pulse does not capture the atrium.

13. The device of claim 1, wherein the second atrial pacing pulse is delivered at an increased energy relative to the first atrial pacing pulse if the cardiac response of the first atrial pacing pulse is classified as a non-captured response.

14. An implantable cardiac device, comprising:

a plurality of implantable cardiac electrodes configured to be electrically coupled to a heart;

sensing circuitry configured to sense cardiac signals;

circuitry configured to

control delivery of a first pacing pulse to an atrium during a first cardiac cycle,

sense for an atrial evoked response following delivery of and associated with the first atrial pacing pulse,

sense for an intrinsic activation of a ventricle during the first cardiac cycle,

deliver a pacing pulse to the ventricle if the intrinsic ventricular activation is not sensed during the first cardiac cycle,

sense in the atrium for a retrograde P-wave, the retrograde P-wave responsive to the ventricular pacing pulse or the intrinsic ventricular activation,

classify the cardiac response to the first atrial pacing pulse as a non-captured response if the retrograde P-wave is detected and the atrial evoked response is not detected,

classify the cardiac response to the first atrial pacing pulse as a captured response if the atrial evoked response is detected,

deliver, during a second cardiac cycle immediately following the first cardiac cycle, a next atrial pacing pulse to the atrium,

delay the next atrial pacing pulse if the retrograde P-wave is detected and the next atrial pacing pulse is scheduled to occur before an atrial effective refractory period (AERP), and

delay the next atrial pacing pulse if the cardiac response of the first atrial pacing pulse is classified as a non-captured response and if a time period between the detected retrograde P-wave and the scheduled delivery time is no greater than the AERP.

15. The device of claim 14, wherein the processor is configured to deliver the next atrial pacing pulse as scheduled if the retrograde P-wave is not detected.

16. The device of claim 14, wherein the next atrial pacing pulse is delayed until after the atrial effective refractory period.

17. The device of claim 14, wherein an energy of the next atrial pacing pulse is increased relative to the first atrial pacing pulse.

18. The device of claim 17, wherein the processor is configured to change the atrial effective refractory period if the next atrial pacing pulse does not produce an evoked response.

19. The device of claim 17, wherein the processor is configured to leave the atrial effective refractory period unchanged if the next atrial pacing pulse produces an evoked response.